What dose of sodium phosphate should be given to an adult with a serum phosphate of 0.39 mmol/L?

Severe Hypophosphatemia Management: Dosing Sodium Phosphate for Serum Phosphate 0.39 mmol/L (1.2 mg/dL)

For an adult with severe hypophosphatemia (serum phosphate 0.39 mmol/L or 1.2 mg/dL), administer intravenous sodium phosphate at a dose of 0.5 mmol/kg (15 mg/kg) infused over 4 hours, which will effectively raise serum phosphate above 1.2 mg/dL in nearly all patients. 1

Severity Classification

• A serum phosphate of 0.39 mmol/L (1.2 mg/dL) represents severe hypophosphatemia, well below the threshold of 1.5 mg/dL (0.48 mmol/L) that defines severe deficiency 2, 3
• This level is also below the 2.0 mg/dL threshold where parenteral supplementation is generally reserved for life-threatening hypophosphatemia 3
• Severe hypophosphatemia at this level can cause cardiac and skeletal muscle weakness, respiratory depression, rhabdomyolysis, and altered mental status 4, 3

Intravenous Phosphate Dosing Protocol

Dose Selection Based on Severity

For serum phosphate <0.5 mg/dL (0.16 mmol/L):

• Administer 0.5 mmol/kg (15 mg/kg) of elemental phosphorus 1
• In a critically ill trauma population, this high-dose regimen (1 mmol/kg) significantly increased mean serum phosphorus from 0.38 mmol/L to 0.93 mmol/L by day 2 5

For serum phosphate 0.5-1.0 mg/dL (0.16-0.32 mmol/L):

• Administer 0.25 mmol/kg (7.7 mg/kg) of elemental phosphorus 1

Since your patient has 0.39 mmol/L (1.2 mg/dL), which falls in the moderate-to-severe range, the appropriate dose is 0.25-0.5 mmol/kg depending on clinical context:

• Use the higher dose (0.5 mmol/kg) if the patient has symptomatic hypophosphatemia (muscle weakness, respiratory compromise, cardiac dysfunction) 1
• Use the moderate dose (0.25-0.32 mmol/kg) if asymptomatic but still requiring correction 5, 1

Infusion Rate and Administration

• Infuse at a rate of 1-3 mmol/hour until serum phosphate reaches at least 2.0 mg/dL 3
• A 4-hour infusion of 10-15 mmol (310-465 mg) phosphorus is safe and effective, raising serum phosphate above 1.2 mg/dL in 27 of 28 seriously ill patients without significant adverse effects 1
• Administer at 7.5 mmol/hour as used successfully in trauma patients 5

Salt Selection: Potassium vs. Sodium Phosphate

• If serum potassium <4 mmol/L: Use potassium phosphate 5
• If serum potassium ≥4 mmol/L: Use sodium phosphate 5
• This approach prevents both hypokalemia and hyperkalemia during phosphate repletion 5

Monitoring Requirements During IV Replacement

• Check serum phosphate, calcium, ionized calcium, potassium, and magnesium every 6-12 hours during active repletion 5, 1
• Monitor for hypocalcemia, as phosphate administration can precipitate calcium levels; mean ionized calcium remained stable in clinical trials but individual variation occurs 5, 1
• Assess for clinical improvement in muscle strength and mental status after infusion 1

Transition to Oral Therapy

Once serum phosphate reaches ≥2.0 mg/dL, transition to oral phosphate supplementation to achieve target range of 2.5-4.5 mg/dL 2, 6:

• Initial oral dose: 750-1,600 mg elemental phosphorus daily, divided into 2-4 doses 2
• For severe deficiency requiring aggressive repletion: Use higher frequency dosing (4-6 times daily initially) since serum phosphate returns to baseline within 1.5 hours after oral intake 2
• Potassium-based phosphate salts are preferred over sodium-based preparations to reduce hypercalciuria risk 2

Critical Precautions and Pitfalls

Avoid Overzealous Phosphate Replacement

• Rapid or excessive IV phosphate can cause severe hypocalcemia without tetany 4
• Oral sodium phosphate can cause marked hyperphosphatemia (peak 3.6-12.4 mg/dL) and significant hypocalcemia 7
• In CRRT patients, phosphate supplementation at 3.0 mmol/L caused hyperphosphatemia in 20% of cases 8

Never Co-Administer with Calcium

• Never give phosphate supplements with calcium-containing foods or supplements at the same time, as intestinal calcium-phosphate precipitation reduces absorption 2
• Separate phosphate and calcium administration by several hours 2

Consider Active Vitamin D Co-Therapy

• If phosphate supplementation is needed for >3 months, add active vitamin D (calcitriol 0.5-0.75 μg daily) to prevent secondary hyperparathyroidism 2
• Phosphate supplementation alone can worsen hyperparathyroidism by stimulating PTH release 4, 2

Special Population: Renal Impairment

• Patients with impaired kidney function have lower risk of hypophosphatemia but higher risk of hyperphosphatemia 6
• Use lower doses and monitor more frequently if eGFR <60 mL/min/1.73m² 2

Target Serum Phosphate Ranges

Population	Target Range
Normal kidney function	2.5-4.5 mg/dL (0.81-1.45 mmol/L) [6]
CKD Stage 3-4	2.7-4.6 mg/dL (0.87-1.49 mmol/L) [4,6]
CKD Stage 5/Dialysis	3.5-5.5 mg/dL (1.13-1.78 mmol/L) [4,6]

Practical Dosing Example

For a 70 kg adult with serum phosphate 0.39 mmol/L (1.2 mg/dL):

• Moderate dose: 0.32 mmol/kg × 70 kg = 22.4 mmol (694 mg) infused over 4 hours at 5.6 mmol/hour 5
• High dose (if symptomatic): 0.5 mmol/kg × 70 kg = 35 mmol (1,085 mg) infused over 4 hours at 8.75 mmol/hour 1